Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
288 studies found for:    CENTRAL SEROUS
Show Display Options
Rank Status Study
1 Unknown  Methotrexate for Central Serous Chorioretinopathy Treatment Trial
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Methotrexate;   Drug: Delayed treatment
2 Completed Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Drug: Anecortave Acetate Sterile suspension 15 mg;   Drug: Anecortave Acetate
3 Completed High-dose Antioxidants for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: antioxidants tablets
4 Recruiting Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Mifepristone;   Drug: Placebo
5 Completed Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Verteporfin PDT, half-dose;   Drug: verteporfin PDT, half-fluence
6 Recruiting The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Photodynamic therapy
7 Completed Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: rhuFab V2 [ranibizumab] ( Lucentis )
8 Completed
Has Results
Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention:
9 Completed Micropulse Diode Laser Treatment for Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: Subthreshold diode micropulse laser
10 Recruiting Eplerenone for Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Eplerenone 50mg
11 Completed Effect of Helicobacter Pylori Treatment on Idiopathic Central Serous Chorioretinopathy (ICSCR)
Condition: Central Serous Chorioretinopathy
Intervention: Drug: omeprazole, Amoxicillin, metronidazole
12 Completed Central Serous Chorioretinopathy: Etiology, Course and Prognosis
Condition: Central Serous Chorioretinopathy
Intervention:
13 Active, not recruiting Micropulse 577nm Laser vs Traditional Laser Treatment in Central Serous Chorioretinopathy
Condition: Central Serous Choroidopathy
Interventions: Device: 577-MPL;   Device: TLT
14 Not yet recruiting A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Interventions: Drug: Eplerenone;   Drug: Maltodextrin
15 Recruiting Prospective Randomized Controlled Treatment Trial for Chronic Central Serous Chorioretinopathy
Condition: Chronic Central Serous Chorioretinopathy
Interventions: Procedure: Half-dose photodynamic therapy (PDT);   Procedure: Micropulse laser (ML) treatment
16 Enrolling by invitation The Effect of Therapy With Bevacizumab in Chronic Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Procedure: intravitreal injection with anterior paracentesis
17 Unknown  Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Device: Micropulse Laser Treatment
18 Active, not recruiting The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy
Condition: Central Serous Chorioretinopathy
Intervention: Drug: Intravitreal Aflibercept Injection
19 Completed Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
Condition: Central Serous Chorioretinopathy
Interventions: Device: subthreshold micropulselaser;   Drug: bevacizumab
20 Enrolling by invitation Treatment Trial for Acute Central Serous Chorioretinopathy
Condition: Acute Central Serous Chorioretinopathy
Interventions: Device: 577-MPL;   Device: 577-TL

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.